Framing medications as common and normal improved patients' willingness to start therapy, whereas numerical adverse effect data had no significant impact.
Ethan Nolin-Halpern, PharmD Candidate
Advertisement
Articles by Ethan Nolin-Halpern, PharmD Candidate
Clinicians can mitigate anemia during cancer treatment by reducing the dose, switching to alternate-day dosing, or providing growth factor support.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
2
New CKD Outcome Set Tells Pharmacists What to Measure
3
GLP-1s and the HCM–Sleep Apnea–Obesity Connection
4
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
5